E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/16/2021 in the Prospect News High Yield Daily.

New Issue: U.S. Acute Care Solutions prices $125 million tap of 6 3/8% notes due 2026 at 103

By Paul A. Harris

Portland, Ore., Aug. 16 – U.S. Acute Care Solutions, LLC priced a $125 million add-on to its 6 3/8% senior secured notes due March 1, 2026 (B2/B-) at 103 with a 5.43% yield to maturity in a Monday drive-by, according to a market source.

The deal came on the rich end of the 102.5 to 103 price talk.

Barclays was the left bookrunner. Joint bookrunners were Deutsche Bank Securities Inc., Capital One Securities Inc. and Apollo Global Securities LLC.

The Canton, Ohio-based physician-owned emergency medicine, hospital and observation services provider plans to use the proceeds plus balance sheet cash to redeem a portion its preferred equity units at par (20% of the original amount) and to finance a common dividend.

Issuer:U.S. Acute Care Solutions, LLC
Amount:$125 million
Maturity:March 1, 2026
Security description:Add-on to 6 3/8% senior secured notes due March 1, 2026
Left bookrunner:Barclays
Joint bookrunners:Deutsche Bank Securities Inc., Capital One Securities Inc. and Apollo Global Securities LLC
Coupon:6 3/8%
Price:103
Yield to maturity: 5.43%
Spread:473 bps
First call:March 1, 2023 at 103.188
Trade date:Aug. 16
Settlement date:Aug. 19 with accrued interest
Ratings:Moody's: B2
S&P: B-
Distribution:Rule 144A and Regulation S for life
Price talk:102.5 to 103
Marketing:Drive-by
Original issue:$375 million priced in February 2021
Fungibility:Add-on notes will become fungible with original notes
Total issue size:$500 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.